Key facts
- This page summarizes Bruce Culleton's Form 4 filing for PROKIDNEY CORP. (PROK).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Mar 2025, 16:42.
Bruce Culleton - 01 Mar 2025 Form 4 Insider Report for PROKIDNEY CORP. (PROK)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- PROK
- Reported as of
- 01 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2025, 16:42:14 UTC
- Prior SEC filing
- 16 Sep 2024
- Next SEC filing
- 03 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Girolamo, attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bruce Culleton filed Form 4 for PROKIDNEY CORP. (PROK) on 04 Mar 2025.
Change
- Previous filing in this sequence was filed on 16 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PROK
transaction
Derivative
Employee stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +1,796,000
- Change %
- Price
- $0.000000
- Shares after
- 1,796,000
- Date
- 01 Mar 2025
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 1,796,000
- Exercise price
- $1.23
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025.